Initiation of Providing “Fukusapo”, an Adverse Drug Reaction Management Supporting Tool for Patients Receiving Treatment with Immune Checkpoint Inhibitors
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; Representative Director, President, Gyo Sagara; “ONO”) and 3H Clinical Trial Inc. (Tokyo, Japan; Representative Director, Hirotaka Takizawa; “3H”) announced that the companies developed and started providing “Fukusapo”, an adverse drug reaction (ADR) management supporting tool for patients as from today, aiming at the ADR management in patients receiving the […]